Stablepharma Ltd
Bath
About Stablepharma Ltd
Stablepharma’s technology platform, StablevaX™ converts existing approved vaccines, therapeutics and diagnostics into fridge free thermostable products that do not require refrigeration to preserve them, thereby addressing the global challenges of the cold chain. Stablepharma’s R&D team have identified up to 60 vaccine candidates that could be suitable for StablevaX™ technology. The company actively collaborates with global vaccine manufacturers, academic institutions and NGOs, to advance their pipeline of thermostable products.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $20.1M
- Last round: Grant (Feb 2025)
- Website: stablepharma.com
- Phone: +44 (0)1225 581 220
Industries & Categories
Biotechnology, Commercial, Health Care, Impact Investing, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/stablepharma-ltd-61283 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.